Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
20.83%
0%
20.83%
6 Months
25.79%
0%
25.79%
1 Year
5.65%
0%
5.65%
2 Years
-11.45%
0%
-11.45%
3 Years
70.38%
0%
70.38%
4 Years
278.09%
0%
278.09%
5 Years
797.33%
0%
797.33%
Ergomed Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
24.70%
EBIT Growth (5y)
58.53%
EBIT to Interest (avg)
13.32
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.27
Sales to Capital Employed (avg)
1.68
Tax Ratio
15.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
29.91%
ROE (avg)
20.60%
Valuation key factors
Factor
Value
P/E Ratio
44
Industry P/E
Price to Book Value
7.71
EV to EBIT
34.89
EV to EBITDA
27.17
EV to Capital Employed
10.17
EV to Sales
4.45
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
29.16%
ROE (Latest)
17.69%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
Bullish
Shareholding Snapshot : Dec 2021
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 114 Foreign Institutions (38.86%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'22
Dec'22
Dec'21
Change(%)
Net Sales
145.30
118.60
22.51%
Operating Profit (PBDIT) excl Other Income
25.50
23.30
9.44%
Interest
0.70
0.40
75.00%
Exceptional Items
-1.90
-5.00
62.00%
Consolidate Net Profit
15.00
12.70
18.11%
Operating Profit Margin (Excl OI)
135.10%
154.00%
-1.89%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2022 is 22.51% vs 37.27% in Dec 2021
Consolidated Net Profit
YoY Growth in year ended Dec 2022 is 18.11% vs 30.93% in Dec 2021
About Ergomed Plc 
Ergomed Plc
Miscellaneous Commercial Services
Ergomed plc is a provider of drug development services to the pharmaceutical industry. The Company operates through two segments: clinical research services (CRS), and drug safety and medical information services (DS&MI). It provides a range of clinical trial planning, management and monitoring services. It is focused on oncology, neurology and immunology, and the development of orphan drugs. It has two businesses: Services Business and Co-Development Business. The Services Business is a clinical research business providing services to the pharmaceutical and biotechnology industry. The Co-Development Business is a portfolio of partnerships with pharmaceutical and biotechnology companies, providing its drug development services in exchange for a carried interest in any revenues attributable to the drug asset, including out licensing milestones, as well as sales of the product. It provides clinical development, trial management and pharmacovigilance services to over 100 clients.
Company Coordinates 
Company Details
1 Occam Court, Occam Road , GUILDFORD None : GU2 7HJ
Registrar Details






